Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Forner, 2012, Hepatocellular carcinoma, Lancet, 379, 1245, 10.1016/S0140-6736(11)61347-0

Polyak, 2009, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits, Nat Rev Cancer, 9, 265, 10.1038/nrc2620

Christiansen, 2006, Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis, Cancer Res, 66, 8319, 10.1158/0008-5472.CAN-06-0410

Tanaka, 2012, Molecular targeted therapies in hepatocellular carcinoma, Semin Oncol, 39, 486, 10.1053/j.seminoncol.2012.05.005

Wadhwa, 2002, An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?, Cell Stress Chaperones, 7, 309, 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2

Wadhwa, 2006, Upregulation of mortalin/ mthsp70/Grp75 contributes to human carcinogenesis, Int J Cancer, 118, 2973, 10.1002/ijc.21773

Mizukoshi, 2001, Cell-cycle dependent tyrosine phosphorylation on mortalin regulates its interaction with fibroblast growth factor-1, Biochem Biophys Res Commun, 280, 1203, 10.1006/bbrc.2001.4225

Wadhwa, 1998, Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member, J Biol Chem, 273, 29586, 10.1074/jbc.273.45.29586

Wadhwa, 2003, Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation, Biochem Biophys Res Commun, 302, 735, 10.1016/S0006-291X(03)00226-2

Yi, 2008, Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence, Mol Cell Proteomics, 7, 315, 10.1074/mcp.M700116-MCP200

Li, 2003, Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray, J Cancer Res Clin Oncol, 129, 43, 10.1007/s00432-002-0396-4

Li, 2001, Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97, World J Gastroenterol, 7, 630, 10.3748/wjg.v7.i5.630

Edmondson, 1954, Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies, Cancer, 7, 462, 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E

Chen, 2008, Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters, Mod Pathol, 21, 1183, 10.1038/modpathol.2008.90

Weidner, 1991, Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma, N Engl J Med, 324, 1, 10.1056/NEJM199101033240101

Thiery, 2002, Epithelial-mesenchymal transitions in tumour progression, Nat Rev Cancer, 2, 442, 10.1038/nrc822

Hartl, 1996, Molecular chaperones in cellular protein folding, Nature, 381, 571, 10.1038/381571a0

Calderwood, 2006, Heat shock proteins in cancer: chaperones of tumorigenesis, Trends Biochem Sci, 31, 164, 10.1016/j.tibs.2006.01.006

Ma, 2006, Mortalin controls centrosome duplication via modulating centrosomal localization of p53, Oncogene, 25, 5377, 10.1038/sj.onc.1209543

Lu, 2011, Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy, Cell Death Differ, 18, 1046, 10.1038/cdd.2010.177

Dundas, 2005, Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival, J Pathol, 205, 74, 10.1002/path.1672

Chen, 2011, Expression of mortalin detected in human liver cancer by tissue microarrays, Anat Rec, 294, 1344, 10.1002/ar.21433

Kimura, 1998, Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry, Liver, 18, 14, 10.1111/j.1600-0676.1998.tb00121.x

Gupta, 2006, Cancer metastasis: building a framework, Cell, 127, 679, 10.1016/j.cell.2006.11.001

Zhou, 2010, HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition, J Am Soc Nephrol, 21, 598, 10.1681/ASN.2009050552

Li, 2011, HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-beta-induced epithelial-mesenchymal transition, J Genet Genomics, 38, 111, 10.1016/j.jgg.2011.02.001